Sperm-associated antigen 9 is a biomarker for early cervical carcinoma (Q28239523)

1

0 references

Deepika Kanojia

2

0 references

Sudha Salhan

3

0 references

Sushma Suri

4

0 references

Anju Gupta

5

0 references

Nirmal Kumar Lohiya

6

0 references

language of work or name

English

0 references

publication date

15 June 2009

0 references

published in

Cancer

0 references

volume

115

0 references

issue

12

0 references

page(s)

2671-83

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.24293

1 reference

7 January 2021

Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Biochemical prognostic factors and risk of relapses in patients with cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Identification and characterization of a novel cancer/testis antigen gene CAGE-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

A Combination of Serum Tumor Markers Identifies High-Risk Patients with Early-Stage Squamous Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

1975-1995 revised anti-cancer serological response: biological significance and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Cancer/testis antigens, gametogenesis and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021

Scaffold proteins of MAP-kinase modules.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24293

7 January 2021